Andrew Neville

Andrew Neville is a Partner at Inflexion Private Equity since September 2016, with extensive experience in board leadership and investment roles across various companies. Currently serving as a Board Director for PROTEROS biostructures GmbH, Upperton Pharma Solutions, and Movera, Andrew has previously held directorships at Medivet and investment management as an Investment Director at Octopus Healthcare. Prior experience includes serving as Associate Director at GI Partners and roles at Three Delta LLP and PwC in corporate finance. Andrew holds an MEng in Mechanical Engineering from The University of Sheffield, where studies were completed from 2001 to 2005, following earlier education at Solihull School.